Bio-Techne Corporation
TECH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,648 | $7,970 | $9,227 | $11,412 |
| - Cash | $145 | $162 | $141 | $178 |
| + Debt | $381 | $444 | $423 | $395 |
| Enterprise Value | $8,884 | $8,252 | $9,510 | $11,629 |
| Revenue | $287 | $317 | $316 | $297 |
| % Growth | -9.6% | 0.2% | 6.4% | – |
| Gross Profit | $190 | $199 | $215 | $194 |
| % Margin | 66.4% | 62.7% | 67.9% | 65.3% |
| EBITDA | $78 | $6 | $68 | $72 |
| % Margin | 27.1% | 2% | 21.5% | 24.3% |
| Net Income | $38 | -$18 | $23 | $35 |
| % Margin | 13.3% | -5.6% | 7.1% | 11.7% |
| EPS Diluted | 0.24 | -0.11 | 0.14 | 0.22 |
| % Growth | 318.2% | -178.6% | -36.4% | – |
| Operating Cash Flow | $28 | $98 | $41 | $84 |
| Capital Expenditures | -$5 | -$5 | -$10 | -$7 |
| Free Cash Flow | $22 | $93 | $31 | $78 |